Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board  >  DNAPrint Genomics, Inc.    DNAG

DNAPRINT GENOMICS, INC. (DNAG)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 10/10 08:38:32 pm
1.0E-6 USD   -90.00%
 SummaryQuotesChartsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board
09/22/2017 09/25/2017 09/26/2017 09/28/2017 10/10/2017 Date
0.001(c) 1.0E-5(c) 1.0E-6(c) 1.0E-5(c) 1.0E-6(c) Last
100 932 650 14 250 2 000 000 23 014 000 Volume
+99900.00% -99.00% -90.00% +900.00% -90.00% Change
More quotes
Company
DNAPrint Genomics, Inc. is engaged in the development of genomics-based products and services for biomedical and forensics.The company offers its products and services to other areas such as pharmacogenomics, genotyping and other consumer products.DNAPrint Genomics was founded by Tony N. Frudakis... 
More about the company
Latest news on DNAPRINT GENOMICS, INC.

- No features available -

More news
Sector news : Biotechnology & Medical Research - NEC
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval -- Update
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
More sector news : Biotechnology & Medical Research - NEC
Chart DNAPRINT GENOMICS, INC.
Duration : Period :
DNAPrint Genomics, Inc. Technical Analysis Chart | DNAG | US23324Q2021 | 4-Traders
Managers
NameTitle
Monica Tamborini Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
DNAPRINT GENOMICS, INC.0.00%0
INCYTE CORPORATION13.96%24 254
QUINTILES IMS HOLDINGS INC33.89%21 711
CELLTRION, INC.--.--%20 802
LONZA GROUP59.15%19 730
ALNYLAM PHARMACEUTICALS, INC.208.84%10 783